Clinical trials
Enrolling by invitation trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
146 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 6 |
| 2020 | 2 |
| 2021 | 8 |
| 2022 | 16 |
| 2023 | 21 |
| 2024 | 38 |
| 2025 | 37 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 146 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 6 |
| Sanofi | 3 |
| Sarepta Therapeutics, Inc. | 3 |
| University Hospital Tuebingen | 3 |
| University Medical Center Goettingen | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Anette Buyken | 2 |
| BioMarin Pharmaceutical | 2 |
| Charite University, Berlin, Germany | 2 |
| LMU Klinikum | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myotonic Dystrophy | 6 |
| Angioedemas, Hereditary | 5 |
| Epilepsy | 5 |
| Hemophilia A | 4 |
| Seizures | 4 |
| Aortic Valve Stenosis | 3 |
| Cardiovascular Diseases | 3 |
| Diabetes Mellitus | 3 |
| Genetic Diseases, Inborn | 3 |
| Hematologic Neoplasms | 3 |
Trials
Showing 26 to 50 of 146. Each trial links to its page on Pharma Observatory.
46 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.